Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfia
|
ENSMUSG00000028565.12 | nuclear factor I/A |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_97776884_97777081 | Nfia | 626 | 0.598117 | 0.57 | 1.6e-06 | Click! |
chr4_97868552_97869863 | Nfia | 10912 | 0.276421 | 0.55 | 6.2e-06 | Click! |
chr4_97773576_97773727 | Nfia | 917 | 0.587868 | 0.52 | 2.1e-05 | Click! |
chr4_97777113_97777438 | Nfia | 333 | 0.753865 | 0.46 | 2.3e-04 | Click! |
chr4_98003613_98004849 | Nfia | 93198 | 0.083951 | 0.45 | 3.5e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_102760289_102761654 | 7.84 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
446 |
0.87 |
chr15_85677376_85679232 | 7.26 |
Lncppara |
long noncoding RNA near Ppara |
24688 |
0.12 |
chr8_12947702_12949640 | 6.98 |
Mcf2l |
mcf.2 transforming sequence-like |
718 |
0.37 |
chr7_100926314_100930096 | 6.96 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
3902 |
0.17 |
chr8_107545084_107547731 | 6.88 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
1395 |
0.4 |
chr2_21367263_21369086 | 6.63 |
Gpr158 |
G protein-coupled receptor 158 |
607 |
0.59 |
chr4_97868552_97869863 | 5.98 |
Nfia |
nuclear factor I/A |
10912 |
0.28 |
chr1_126828978_126829702 | 5.91 |
Nckap5 |
NCK-associated protein 5 |
1141 |
0.62 |
chr15_86028772_86030702 | 5.76 |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
4466 |
0.22 |
chr5_47984037_47984783 | 5.75 |
Slit2 |
slit guidance ligand 2 |
584 |
0.71 |
chr13_105444000_105445296 | 5.73 |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
1009 |
0.69 |
chr8_17532221_17533470 | 5.57 |
Csmd1 |
CUB and Sushi multiple domains 1 |
2436 |
0.46 |
chr13_58809397_58810364 | 5.46 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
1189 |
0.34 |
chr9_52678302_52679671 | 5.44 |
AI593442 |
expressed sequence AI593442 |
443 |
0.69 |
chr15_85679298_85680211 | 5.30 |
Lncppara |
long noncoding RNA near Ppara |
24019 |
0.12 |
chr9_56864653_56866648 | 5.29 |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
617 |
0.51 |
chr1_129273098_129274282 | 5.17 |
Thsd7b |
thrombospondin, type I, domain containing 7B |
205 |
0.95 |
chr8_122751484_122752386 | 5.13 |
C230057M02Rik |
RIKEN cDNA C230057M02 gene |
390 |
0.75 |
chr16_5884597_5886147 | 5.12 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
17 |
0.99 |
chr8_121730928_121732115 | 5.10 |
Jph3 |
junctophilin 3 |
954 |
0.49 |
chr15_81936444_81938042 | 5.10 |
Csdc2 |
cold shock domain containing C2, RNA binding |
261 |
0.82 |
chrX_143664015_143665455 | 5.08 |
Pak3 |
p21 (RAC1) activated kinase 3 |
156 |
0.98 |
chr13_99446279_99447668 | 5.05 |
Map1b |
microtubule-associated protein 1B |
647 |
0.72 |
chr14_59626952_59628434 | 5.05 |
Shisa2 |
shisa family member 2 |
504 |
0.76 |
chr7_49247685_49248635 | 5.00 |
Nav2 |
neuron navigator 2 |
1315 |
0.51 |
chr9_58197310_58202560 | 4.86 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr2_25877424_25878675 | 4.86 |
Kcnt1 |
potassium channel, subfamily T, member 1 |
168 |
0.93 |
chr10_52704169_52705266 | 4.85 |
Gm47624 |
predicted gene, 47624 |
10879 |
0.19 |
chr3_108410436_108412210 | 4.83 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
4229 |
0.11 |
chrX_43427105_43427755 | 4.75 |
Tenm1 |
teneurin transmembrane protein 1 |
1573 |
0.42 |
chr4_82403917_82404758 | 4.74 |
n-R5s188 |
nuclear encoded rRNA 5S 188 |
35073 |
0.2 |
chr5_124184090_124186568 | 4.69 |
Pitpnm2 |
phosphatidylinositol transfer protein, membrane-associated 2 |
211 |
0.9 |
chr6_8949063_8949350 | 4.68 |
Nxph1 |
neurexophilin 1 |
470 |
0.9 |
chr11_5802324_5803834 | 4.57 |
Pgam2 |
phosphoglycerate mutase 2 |
654 |
0.56 |
chr9_83145662_83146804 | 4.56 |
Hmgn3 |
high mobility group nucleosomal binding domain 3 |
237 |
0.54 |
chr6_119328752_119331284 | 4.54 |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
739 |
0.43 |
chr10_80298461_80300404 | 4.53 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
341 |
0.69 |
chr7_99267573_99269343 | 4.51 |
Map6 |
microtubule-associated protein 6 |
52 |
0.95 |
chr13_34725859_34726844 | 4.50 |
Gm47151 |
predicted gene, 47151 |
5600 |
0.13 |
chr3_101379658_101381123 | 4.49 |
Igsf3 |
immunoglobulin superfamily, member 3 |
2052 |
0.26 |
chr2_146745280_146745983 | 4.45 |
Gm14111 |
predicted gene 14111 |
10074 |
0.27 |
chr15_82255980_82257145 | 4.39 |
1500009C09Rik |
RIKEN cDNA 1500009C09 gene |
539 |
0.56 |
chrX_6091588_6092836 | 4.37 |
Gm26618 |
predicted gene, 26618 |
57 |
0.96 |
chr7_44441951_44442938 | 4.36 |
Lrrc4b |
leucine rich repeat containing 4B |
41 |
0.93 |
chr17_81737002_81738450 | 4.35 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
651 |
0.81 |
chr17_35700709_35702577 | 4.30 |
Ddr1 |
discoidin domain receptor family, member 1 |
321 |
0.72 |
chr3_45379351_45381850 | 4.30 |
Pcdh10 |
protocadherin 10 |
2033 |
0.25 |
chr5_74197172_74198949 | 4.29 |
Rasl11b |
RAS-like, family 11, member B |
169 |
0.94 |
chr6_8955848_8957226 | 4.28 |
Nxph1 |
neurexophilin 1 |
6861 |
0.32 |
chr1_75277211_75278430 | 4.25 |
Resp18 |
regulated endocrine-specific protein 18 |
464 |
0.62 |
chr12_113141740_113143605 | 4.24 |
Crip2 |
cysteine rich protein 2 |
136 |
0.92 |
chr14_55054119_55054818 | 4.23 |
Gm20687 |
predicted gene 20687 |
477 |
0.41 |
chr19_5297797_5299076 | 4.23 |
Gal3st3 |
galactose-3-O-sulfotransferase 3 |
105 |
0.9 |
chr8_111889675_111890918 | 4.21 |
Gm23853 |
predicted gene, 23853 |
10992 |
0.13 |
chrX_21360791_21361960 | 4.20 |
Gm5124 |
predicted pseudogene 5124 |
435 |
0.85 |
chr8_84793544_84794414 | 4.17 |
Nfix |
nuclear factor I/X |
6045 |
0.1 |
chr9_27299227_27300541 | 4.15 |
Igsf9b |
immunoglobulin superfamily, member 9B |
656 |
0.72 |
chr2_3120387_3121386 | 4.11 |
Fam171a1 |
family with sequence similarity 171, member A1 |
2201 |
0.35 |
chr5_49524881_49525095 | 4.10 |
Kcnip4 |
Kv channel interacting protein 4 |
81 |
0.97 |
chr2_42652202_42653456 | 4.09 |
Lrp1b |
low density lipoprotein-related protein 1B |
97 |
0.98 |
chr3_35481945_35482453 | 4.08 |
Gm7733 |
predicted gene 7733 |
55601 |
0.12 |
chr5_111421306_111422790 | 4.08 |
Gm43119 |
predicted gene 43119 |
1541 |
0.35 |
chr2_25580658_25582212 | 4.08 |
Ajm1 |
apical junction component 1 |
293 |
0.72 |
chr8_109250884_109251908 | 4.07 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1530 |
0.52 |
chr6_32584464_32585789 | 4.07 |
Plxna4 |
plexin A4 |
3066 |
0.3 |
chr17_43157421_43159105 | 4.07 |
E130008D07Rik |
RIKEN cDNA E130008D07 gene |
3 |
0.99 |
chr1_193369065_193370282 | 4.06 |
Camk1g |
calcium/calmodulin-dependent protein kinase I gamma |
552 |
0.7 |
chr4_36950134_36952137 | 4.05 |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
88 |
0.97 |
chr2_163396823_163398215 | 4.01 |
Jph2 |
junctophilin 2 |
430 |
0.77 |
chr10_22191023_22191692 | 4.00 |
Raet1e |
retinoic acid early transcript 1E |
17438 |
0.1 |
chr16_41533623_41534478 | 4.00 |
Lsamp |
limbic system-associated membrane protein |
631 |
0.84 |
chr15_72806569_72807700 | 3.97 |
Peg13 |
paternally expressed 13 |
3190 |
0.32 |
chr8_12926230_12928559 | 3.96 |
Mcf2l |
mcf.2 transforming sequence-like |
762 |
0.52 |
chr10_29143400_29144848 | 3.94 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr11_61505191_61505873 | 3.93 |
B9d1 |
B9 protein domain 1 |
277 |
0.64 |
chr7_16946370_16947636 | 3.93 |
Pnmal2 |
PNMA-like 2 |
2321 |
0.14 |
chr8_11730035_11730943 | 3.93 |
Arhgef7 |
Rho guanine nucleotide exchange factor (GEF7) |
2312 |
0.16 |
chr13_34125172_34126139 | 3.92 |
Tubb2b |
tubulin, beta 2B class IIB |
4699 |
0.12 |
chr7_130260560_130262022 | 3.92 |
Fgfr2 |
fibroblast growth factor receptor 2 |
566 |
0.84 |
chr12_87026152_87027307 | 3.90 |
Tmem63c |
transmembrane protein 63c |
113 |
0.95 |
chr2_180388160_180389480 | 3.89 |
Mir1a-1 |
microRNA 1a-1 |
228 |
0.89 |
chr10_121836526_121837955 | 3.89 |
Gm48804 |
predicted gene, 48804 |
5182 |
0.22 |
chr2_113828248_113829427 | 3.88 |
Scg5 |
secretogranin V |
75 |
0.97 |
chrX_82814349_82815696 | 3.85 |
Gm14741 |
predicted gene 14741 |
56584 |
0.15 |
chr14_103777998_103779182 | 3.85 |
Ednrb |
endothelin receptor type B |
65105 |
0.11 |
chr1_11413602_11414901 | 3.84 |
A830018L16Rik |
RIKEN cDNA A830018L16 gene |
18 |
0.98 |
chr18_37810077_37810795 | 3.84 |
BC037039 |
cDNA sequence BC037039 |
2514 |
0.09 |
chr18_69576097_69576977 | 3.83 |
Tcf4 |
transcription factor 4 |
13202 |
0.24 |
chr6_36808560_36810410 | 3.83 |
Ptn |
pleiotrophin |
694 |
0.79 |
chr4_102256022_102256825 | 3.82 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
1193 |
0.63 |
chr7_51510582_51511765 | 3.80 |
Ano5 |
anoctamin 5 |
66 |
0.98 |
chr4_137681085_137682497 | 3.80 |
Rap1gap |
Rap1 GTPase-activating protein |
124 |
0.96 |
chr13_34127276_34127957 | 3.79 |
Tubb2b |
tubulin, beta 2B class IIB |
2738 |
0.15 |
chr1_109982396_109983459 | 3.79 |
Cdh7 |
cadherin 7, type 2 |
54 |
0.99 |
chr4_33188674_33189803 | 3.78 |
Pm20d2 |
peptidase M20 domain containing 2 |
195 |
0.93 |
chr14_32028558_32029449 | 3.77 |
Galnt15 |
polypeptide N-acetylgalactosaminyltransferase 15 |
14 |
0.97 |
chr3_108153841_108154889 | 3.77 |
Gpr61 |
G protein-coupled receptor 61 |
517 |
0.6 |
chr13_41355674_41356040 | 3.77 |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated gene 9 |
3390 |
0.18 |
chr5_139422893_139423950 | 3.75 |
Gper1 |
G protein-coupled estrogen receptor 1 |
141 |
0.93 |
chr3_53043747_53045351 | 3.75 |
Gm42901 |
predicted gene 42901 |
2794 |
0.16 |
chr3_30546274_30547260 | 3.75 |
Mecom |
MDS1 and EVI1 complex locus |
1241 |
0.35 |
chr4_82499658_82501360 | 3.74 |
Nfib |
nuclear factor I/B |
1193 |
0.5 |
chr2_151969889_151971485 | 3.73 |
Fam110a |
family with sequence similarity 110, member A |
2707 |
0.18 |
chr6_42708913_42710173 | 3.72 |
Tcaf1 |
TRPM8 channel-associated factor 1 |
528 |
0.62 |
chr2_121295426_121296424 | 3.67 |
Gm14978 |
predicted gene 14978 |
83 |
0.85 |
chr4_22485878_22486449 | 3.66 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
2203 |
0.26 |
chr9_78377654_78378912 | 3.65 |
Ooep |
oocyte expressed protein |
442 |
0.65 |
chr6_91212520_91213912 | 3.64 |
Fbln2 |
fibulin 2 |
385 |
0.81 |
chr3_8663653_8664237 | 3.63 |
Hey1 |
hairy/enhancer-of-split related with YRPW motif 1 |
2680 |
0.2 |
chr17_93201490_93204144 | 3.61 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
741 |
0.65 |
chr4_97582473_97584218 | 3.60 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
1251 |
0.53 |
chr9_71591283_71592381 | 3.60 |
Myzap |
myocardial zonula adherens protein |
433 |
0.84 |
chr7_62376325_62378263 | 3.59 |
Magel2 |
melanoma antigen, family L, 2 |
284 |
0.9 |
chr5_111425949_111427685 | 3.58 |
Gm43119 |
predicted gene 43119 |
3228 |
0.22 |
chr19_42201012_42202482 | 3.57 |
Sfrp5 |
secreted frizzled-related sequence protein 5 |
505 |
0.71 |
chr1_194623571_194625393 | 3.56 |
Plxna2 |
plexin A2 |
4657 |
0.21 |
chr11_11113816_11114856 | 3.55 |
Vwc2 |
von Willebrand factor C domain containing 2 |
113 |
0.98 |
chr3_89520167_89521303 | 3.52 |
Kcnn3 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 |
571 |
0.71 |
chr15_68931535_68932379 | 3.52 |
Khdrbs3 |
KH domain containing, RNA binding, signal transduction associated 3 |
1889 |
0.38 |
chr2_152931122_152933148 | 3.52 |
Foxs1 |
forkhead box S1 |
1073 |
0.38 |
chr2_91119045_91119896 | 3.52 |
Mybpc3 |
myosin binding protein C, cardiac |
1326 |
0.3 |
chr12_27159928_27160727 | 3.50 |
Gm9866 |
predicted gene 9866 |
16 |
0.99 |
chr9_58156326_58158409 | 3.50 |
Islr |
immunoglobulin superfamily containing leucine-rich repeat |
1178 |
0.35 |
chr3_96181539_96182795 | 3.50 |
Sv2a |
synaptic vesicle glycoprotein 2 a |
1016 |
0.22 |
chr13_83722440_83722673 | 3.49 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1175 |
0.38 |
chr17_17402413_17403374 | 3.48 |
Lix1 |
limb and CNS expressed 1 |
221 |
0.91 |
chr7_144175485_144176434 | 3.48 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
430 |
0.88 |
chr18_37143430_37144634 | 3.47 |
Pcdhac2 |
protocadherin alpha subfamily C, 2 |
529 |
0.67 |
chr5_119804344_119805024 | 3.47 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
2983 |
0.24 |
chr16_13357876_13359918 | 3.47 |
Mrtfb |
myocardin related transcription factor B |
476 |
0.83 |
chr13_83735558_83735982 | 3.47 |
Gm33366 |
predicted gene, 33366 |
2765 |
0.16 |
chr1_59515761_59516856 | 3.46 |
Gm973 |
predicted gene 973 |
44 |
0.96 |
chr15_43169577_43170879 | 3.46 |
Rspo2 |
R-spondin 2 |
590 |
0.82 |
chr8_92827121_92828679 | 3.45 |
Mmp2 |
matrix metallopeptidase 2 |
609 |
0.71 |
chr1_152955506_152956322 | 3.45 |
Nmnat2 |
nicotinamide nucleotide adenylyltransferase 2 |
640 |
0.67 |
chr7_84528418_84529713 | 3.44 |
Gm2115 |
predicted gene 2115 |
73 |
0.97 |
chr4_87570464_87571010 | 3.44 |
Gm12604 |
predicted gene 12604 |
10052 |
0.3 |
chr15_11036089_11037859 | 3.44 |
Rxfp3 |
relaxin family peptide receptor 3 |
1017 |
0.52 |
chr11_76435834_76437863 | 3.42 |
Abr |
active BCR-related gene |
372 |
0.87 |
chr1_137221151_137222186 | 3.42 |
Gm25609 |
predicted gene, 25609 |
6021 |
0.25 |
chr18_57134532_57135579 | 3.42 |
Megf10 |
multiple EGF-like-domains 10 |
1965 |
0.32 |
chr1_77505286_77506951 | 3.42 |
Epha4 |
Eph receptor A4 |
8961 |
0.18 |
chr15_89840994_89842160 | 3.42 |
Syt10 |
synaptotagmin X |
283 |
0.93 |
chr1_25228097_25229399 | 3.42 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
78 |
0.96 |
chr5_119972869_119973766 | 3.42 |
Gm38554 |
predicted gene, 38554 |
14074 |
0.21 |
chr19_5463295_5464559 | 3.40 |
Fibp |
fibroblast growth factor (acidic) intracellular binding protein |
283 |
0.68 |
chr4_141010412_141011785 | 3.40 |
Mfap2 |
microfibrillar-associated protein 2 |
454 |
0.71 |
chr1_192191161_192191781 | 3.39 |
Kcnh1 |
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
697 |
0.69 |
chr7_79501250_79502506 | 3.39 |
Mir9-3hg |
Mir9-3 host gene |
1757 |
0.18 |
chr10_106469534_106470969 | 3.38 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
88 |
0.97 |
chr2_80128704_80129752 | 3.38 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
230 |
0.94 |
chr15_103503210_103504096 | 3.38 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
376 |
0.81 |
chr2_145860106_145862208 | 3.38 |
Rin2 |
Ras and Rab interactor 2 |
1487 |
0.37 |
chr19_36534168_36535379 | 3.37 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
19866 |
0.2 |
chr2_77701567_77703605 | 3.37 |
Zfp385b |
zinc finger protein 385B |
686 |
0.8 |
chr9_83686101_83687074 | 3.36 |
Gm36120 |
predicted gene, 36120 |
938 |
0.58 |
chrX_74328789_74330084 | 3.36 |
Plxna3 |
plexin A3 |
370 |
0.67 |
chr5_111424407_111425623 | 3.36 |
Gm43119 |
predicted gene 43119 |
1426 |
0.38 |
chr8_54954519_54955779 | 3.34 |
Gpm6a |
glycoprotein m6a |
306 |
0.88 |
chr16_36783835_36785099 | 3.33 |
Slc15a2 |
solute carrier family 15 (H+/peptide transporter), member 2 |
325 |
0.8 |
chr3_152980951_152982389 | 3.33 |
St6galnac5 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 |
382 |
0.86 |
chr15_21110687_21111815 | 3.32 |
Cdh12 |
cadherin 12 |
201 |
0.94 |
chr17_75177945_75179637 | 3.31 |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
19 |
0.98 |
chr5_66745428_66746731 | 3.31 |
Limch1 |
LIM and calponin homology domains 1 |
190 |
0.94 |
chr14_110754559_110755226 | 3.31 |
Slitrk6 |
SLIT and NTRK-like family, member 6 |
257 |
0.91 |
chr12_95691954_95693678 | 3.31 |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
590 |
0.73 |
chr8_106871786_106872398 | 3.30 |
Has3 |
hyaluronan synthase 3 |
1201 |
0.38 |
chr1_167660325_167661484 | 3.29 |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
28333 |
0.21 |
chr4_143298537_143299593 | 3.29 |
Pdpn |
podoplanin |
398 |
0.83 |
chr4_82495480_82496022 | 3.29 |
Nfib |
nuclear factor I/B |
3565 |
0.25 |
chr15_85673548_85673944 | 3.28 |
Lncppara |
long noncoding RNA near Ppara |
20130 |
0.13 |
chrX_152369113_152369413 | 3.28 |
3010001F23Rik |
RIKEN cDNA 3010001F23 gene |
235 |
0.75 |
chr2_67565316_67565790 | 3.27 |
B3galt1 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
318 |
0.9 |
chr9_25483755_25485057 | 3.27 |
Eepd1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
1539 |
0.42 |
chr1_134232926_134233818 | 3.27 |
Adora1 |
adenosine A1 receptor |
1206 |
0.39 |
chr7_126274826_126275043 | 3.27 |
Sbk1 |
SH3-binding kinase 1 |
1534 |
0.28 |
chr7_45785390_45787192 | 3.26 |
Lmtk3 |
lemur tyrosine kinase 3 |
266 |
0.77 |
chr5_134746440_134747928 | 3.26 |
Eln |
elastin |
62 |
0.61 |
chr1_93100315_93101980 | 3.25 |
Kif1a |
kinesin family member 1A |
675 |
0.62 |
chrX_60895147_60896014 | 3.25 |
Gm14662 |
predicted gene 14662 |
1927 |
0.26 |
chr6_107530820_107531278 | 3.25 |
Lrrn1 |
leucine rich repeat protein 1, neuronal |
1281 |
0.51 |
chr4_49842278_49843034 | 3.25 |
Grin3a |
glutamate receptor ionotropic, NMDA3A |
2893 |
0.36 |
chr12_41485290_41486156 | 3.24 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
708 |
0.74 |
chr11_77486623_77487566 | 3.24 |
Ankrd13b |
ankyrin repeat domain 13b |
2572 |
0.17 |
chr11_60141098_60141590 | 3.24 |
Rai1 |
retinoic acid induced 1 |
1085 |
0.44 |
chr10_81229656_81230911 | 3.23 |
Atcay |
ataxia, cerebellar, Cayman type |
502 |
0.53 |
chr12_86077202_86078994 | 3.22 |
Gm48008 |
predicted gene, 48008 |
546 |
0.57 |
chr7_82869041_82870364 | 3.22 |
Mex3b |
mex3 RNA binding family member B |
2369 |
0.22 |
chr11_7063654_7064371 | 3.21 |
Adcy1 |
adenylate cyclase 1 |
523 |
0.85 |
chr5_12383136_12384552 | 3.21 |
Sema3d |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D |
338 |
0.91 |
chr18_40258245_40258964 | 3.21 |
Gm31087 |
predicted gene, 31087 |
109 |
0.63 |
chr4_155215199_155216584 | 3.21 |
Ski |
ski sarcoma viral oncogene homolog (avian) |
6644 |
0.18 |
chr13_83715222_83716973 | 3.20 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5284 |
0.15 |
chr17_85679503_85681370 | 3.20 |
Six2 |
sine oculis-related homeobox 2 |
7818 |
0.18 |
chr13_8202516_8203999 | 3.20 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
335 |
0.87 |
chr7_111778295_111780348 | 3.20 |
Galnt18 |
polypeptide N-acetylgalactosaminyltransferase 18 |
656 |
0.76 |
chr7_141079729_141081054 | 3.20 |
Pkp3 |
plakophilin 3 |
611 |
0.5 |
chr13_20473087_20474265 | 3.20 |
Gm32036 |
predicted gene, 32036 |
186 |
0.89 |
chr5_19907724_19909563 | 3.19 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
682 |
0.82 |
chr16_21211195_21211772 | 3.19 |
Ephb3 |
Eph receptor B3 |
388 |
0.84 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 15.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.8 | 7.6 | GO:0021564 | vagus nerve development(GO:0021564) |
3.7 | 11.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
3.6 | 10.7 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
3.5 | 10.6 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
3.5 | 10.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
3.5 | 14.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
3.5 | 24.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
3.4 | 10.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
3.1 | 9.4 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
3.1 | 9.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.0 | 9.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.9 | 2.9 | GO:0070384 | Harderian gland development(GO:0070384) |
2.8 | 8.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
2.7 | 10.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.6 | 20.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.6 | 12.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
2.4 | 9.6 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
2.4 | 2.4 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) dorsal root ganglion development(GO:1990791) |
2.4 | 4.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
2.4 | 2.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.3 | 9.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
2.3 | 7.0 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.3 | 23.4 | GO:0071625 | vocalization behavior(GO:0071625) |
2.3 | 6.9 | GO:0060437 | lung growth(GO:0060437) |
2.2 | 13.4 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
2.2 | 8.8 | GO:0060174 | limb bud formation(GO:0060174) |
2.2 | 17.3 | GO:0021559 | trigeminal nerve development(GO:0021559) |
2.1 | 6.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
2.1 | 10.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
2.1 | 4.1 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.1 | 8.2 | GO:0030035 | microspike assembly(GO:0030035) |
2.0 | 10.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
2.0 | 6.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
2.0 | 11.8 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.9 | 5.8 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.9 | 5.8 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
1.9 | 15.0 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
1.9 | 1.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.8 | 7.4 | GO:0090427 | activation of meiosis(GO:0090427) |
1.8 | 5.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.8 | 3.6 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
1.8 | 10.8 | GO:0031223 | auditory behavior(GO:0031223) |
1.8 | 7.2 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.8 | 10.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.8 | 1.8 | GO:0033058 | directional locomotion(GO:0033058) |
1.8 | 5.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.8 | 5.3 | GO:0060166 | olfactory pit development(GO:0060166) |
1.8 | 5.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.7 | 3.5 | GO:0021586 | pons maturation(GO:0021586) |
1.7 | 3.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.7 | 3.5 | GO:0060594 | mammary gland specification(GO:0060594) |
1.7 | 3.4 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.7 | 6.7 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.7 | 13.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.7 | 5.0 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.7 | 6.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.6 | 11.5 | GO:0097264 | self proteolysis(GO:0097264) |
1.6 | 1.6 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
1.6 | 26.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.6 | 4.9 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.6 | 6.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.6 | 3.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.6 | 6.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.6 | 7.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.6 | 3.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
1.6 | 9.3 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
1.6 | 4.7 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
1.5 | 6.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.5 | 9.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.5 | 7.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.5 | 35.0 | GO:0001964 | startle response(GO:0001964) |
1.5 | 3.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.5 | 10.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.5 | 4.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.5 | 19.5 | GO:0060074 | synapse maturation(GO:0060074) |
1.5 | 3.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.5 | 3.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.5 | 5.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.5 | 14.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.5 | 4.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.4 | 2.9 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
1.4 | 10.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.4 | 11.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.4 | 4.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.4 | 1.4 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
1.4 | 1.4 | GO:2000987 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
1.4 | 1.4 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
1.4 | 4.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.4 | 4.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.4 | 4.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.4 | 4.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.4 | 4.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
1.4 | 2.7 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.3 | 5.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.3 | 2.6 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.3 | 5.3 | GO:0007412 | axon target recognition(GO:0007412) |
1.3 | 2.6 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.3 | 2.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.3 | 2.5 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.3 | 5.0 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.3 | 5.0 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.2 | 3.7 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.2 | 1.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.2 | 3.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.2 | 2.5 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.2 | 4.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.2 | 6.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.2 | 4.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.2 | 7.3 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
1.2 | 1.2 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.2 | 2.4 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
1.2 | 4.9 | GO:0030091 | protein repair(GO:0030091) |
1.2 | 7.3 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.2 | 3.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.2 | 3.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.2 | 6.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.2 | 2.4 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.2 | 3.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.2 | 6.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
1.2 | 8.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.2 | 3.6 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
1.2 | 60.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.2 | 7.1 | GO:0002118 | aggressive behavior(GO:0002118) |
1.2 | 2.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.2 | 3.5 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.2 | 3.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.1 | 4.6 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
1.1 | 2.3 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.1 | 3.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.1 | 4.5 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.1 | 3.3 | GO:1990035 | calcium ion import into cell(GO:1990035) |
1.1 | 4.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.1 | 8.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.1 | 7.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.1 | 2.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.1 | 1.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
1.1 | 6.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.1 | 2.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.1 | 3.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.1 | 2.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.1 | 4.2 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
1.1 | 2.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.1 | 1.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.1 | 4.2 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
1.1 | 9.5 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.0 | 2.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
1.0 | 6.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.0 | 31.1 | GO:0019228 | neuronal action potential(GO:0019228) |
1.0 | 1.0 | GO:0021557 | oculomotor nerve development(GO:0021557) |
1.0 | 1.0 | GO:0021794 | thalamus development(GO:0021794) |
1.0 | 4.1 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
1.0 | 2.0 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
1.0 | 1.0 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
1.0 | 1.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.0 | 3.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.0 | 1.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.0 | 4.0 | GO:0001927 | exocyst assembly(GO:0001927) |
1.0 | 1.0 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
1.0 | 1.0 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
1.0 | 3.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.0 | 2.0 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
1.0 | 4.9 | GO:0031000 | response to caffeine(GO:0031000) |
1.0 | 6.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.0 | 3.9 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.0 | 2.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.0 | 3.9 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.0 | 2.9 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.0 | 1.0 | GO:0051794 | regulation of catagen(GO:0051794) |
1.0 | 4.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.0 | 3.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.0 | 13.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
1.0 | 1.9 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.9 | 2.8 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.9 | 10.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.9 | 1.9 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.9 | 1.9 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.9 | 2.8 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.9 | 3.8 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.9 | 2.8 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.9 | 2.8 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.9 | 66.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.9 | 1.9 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.9 | 2.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.9 | 1.9 | GO:0001757 | somite specification(GO:0001757) |
0.9 | 1.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.9 | 0.9 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.9 | 1.8 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.9 | 0.9 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.9 | 1.8 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.9 | 0.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.9 | 2.7 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.9 | 0.9 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.9 | 3.6 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.9 | 0.9 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.9 | 1.8 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.9 | 6.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.9 | 7.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.9 | 7.0 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.9 | 0.9 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.9 | 4.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.9 | 0.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.9 | 2.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.9 | 0.9 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.9 | 1.7 | GO:0008355 | olfactory learning(GO:0008355) |
0.9 | 3.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.9 | 6.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.9 | 2.6 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.8 | 12.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.8 | 0.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.8 | 8.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.8 | 2.5 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.8 | 3.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.8 | 2.5 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.8 | 4.2 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.8 | 2.5 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.8 | 4.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.8 | 2.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.8 | 1.6 | GO:0002159 | desmosome assembly(GO:0002159) |
0.8 | 1.6 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.8 | 0.8 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.8 | 1.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.8 | 1.6 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.8 | 1.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.8 | 4.8 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.8 | 2.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.8 | 2.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.8 | 3.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.8 | 4.7 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.8 | 3.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.8 | 1.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.8 | 2.3 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.8 | 1.6 | GO:0061743 | motor learning(GO:0061743) |
0.8 | 2.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.8 | 2.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.8 | 3.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.8 | 3.9 | GO:0015884 | folic acid transport(GO:0015884) |
0.8 | 3.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.8 | 1.5 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.8 | 3.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.8 | 1.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.8 | 2.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.8 | 3.0 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.8 | 0.8 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.8 | 0.8 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.8 | 4.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.8 | 2.3 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.8 | 0.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.7 | 1.5 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.7 | 1.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.7 | 0.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.7 | 4.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.7 | 3.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.7 | 3.0 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.7 | 1.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.7 | 2.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.7 | 2.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.7 | 0.7 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.7 | 0.7 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.7 | 2.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.7 | 2.9 | GO:0014028 | notochord formation(GO:0014028) |
0.7 | 3.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.7 | 13.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.7 | 2.8 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.7 | 2.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.7 | 2.8 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.7 | 3.5 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.7 | 2.8 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.7 | 4.8 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.7 | 6.9 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.7 | 1.4 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.7 | 2.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.7 | 0.7 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.7 | 0.7 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.7 | 2.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.7 | 0.7 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.7 | 5.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.7 | 6.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.7 | 2.7 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.7 | 0.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.7 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.7 | 2.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.7 | 1.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.7 | 4.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.7 | 2.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.7 | 7.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.7 | 8.5 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.7 | 0.7 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.7 | 1.3 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.7 | 2.6 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.6 | 1.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.6 | 1.3 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.6 | 3.2 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.6 | 4.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.6 | 0.6 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.6 | 2.5 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.6 | 1.9 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.6 | 1.3 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.6 | 2.5 | GO:0070141 | response to UV-A(GO:0070141) |
0.6 | 1.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.6 | 1.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.6 | 10.0 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.6 | 1.9 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.6 | 3.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.6 | 0.6 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.6 | 1.2 | GO:0061055 | myotome development(GO:0061055) |
0.6 | 3.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.6 | 1.2 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.6 | 1.8 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.6 | 3.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.6 | 6.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.6 | 62.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.6 | 1.8 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.6 | 4.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.6 | 0.6 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.6 | 2.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.6 | 0.6 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.6 | 1.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.6 | 1.2 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.6 | 1.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.6 | 11.7 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.6 | 14.6 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.6 | 1.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.6 | 2.9 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.6 | 5.7 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.6 | 2.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.6 | 1.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.6 | 0.6 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.6 | 1.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.6 | 1.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.6 | 1.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.6 | 6.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.6 | 1.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.6 | 2.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.6 | 1.1 | GO:0009629 | response to gravity(GO:0009629) |
0.6 | 0.6 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.6 | 2.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.5 | 1.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.5 | 1.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.5 | 1.1 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.5 | 0.5 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.5 | 1.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.5 | 1.6 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.5 | 6.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.5 | 2.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 2.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.5 | 2.1 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.5 | 2.6 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.5 | 1.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 2.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.5 | 1.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.5 | 1.0 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.5 | 1.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.5 | 1.5 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.5 | 1.5 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.5 | 42.8 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.5 | 2.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.5 | 1.0 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.5 | 2.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 | 10.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.5 | 2.5 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.5 | 3.0 | GO:0043586 | tongue development(GO:0043586) |
0.5 | 1.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.5 | 1.5 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.5 | 0.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.5 | 2.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.5 | 1.5 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.5 | 0.5 | GO:0030432 | peristalsis(GO:0030432) |
0.5 | 1.5 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.5 | 1.0 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.5 | 0.5 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.5 | 1.9 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.5 | 2.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.5 | 3.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 1.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.5 | 2.4 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.5 | 0.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.5 | 0.9 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.5 | 2.8 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.5 | 0.9 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.5 | 0.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 1.4 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.5 | 0.5 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.5 | 2.8 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
0.5 | 3.2 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.5 | 5.9 | GO:1900274 | regulation of phospholipase C activity(GO:1900274) |
0.5 | 0.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.5 | 0.9 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 1.4 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.5 | 0.9 | GO:0060618 | nipple development(GO:0060618) |
0.5 | 2.7 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.5 | 3.6 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.5 | 0.5 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.4 | 3.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 1.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.4 | 0.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.4 | 2.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.4 | 0.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 0.9 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.4 | 0.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 0.4 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.4 | 0.4 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.4 | 7.0 | GO:0007616 | long-term memory(GO:0007616) |
0.4 | 1.8 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.4 | 1.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 1.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 0.9 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 0.9 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.4 | 1.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.4 | 0.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 4.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.4 | 3.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.4 | 0.9 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.4 | 0.4 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.4 | 0.4 | GO:0048382 | mesendoderm development(GO:0048382) |
0.4 | 2.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.4 | 0.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 1.7 | GO:0048167 | regulation of synaptic plasticity(GO:0048167) |
0.4 | 5.9 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.4 | 0.4 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.4 | 1.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 0.4 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.4 | 4.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.4 | 0.8 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 1.7 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.4 | 0.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.4 | 1.3 | GO:0007567 | parturition(GO:0007567) |
0.4 | 5.0 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.4 | 1.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.4 | 0.8 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.4 | 1.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.4 | 1.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 0.4 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.4 | 0.4 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.4 | 4.5 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.4 | 0.8 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.4 | 1.6 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.4 | 3.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 0.4 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.4 | 3.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 1.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 0.4 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.4 | 0.8 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.4 | 0.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.4 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.4 | 1.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.4 | 3.1 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 2.7 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.4 | 1.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.4 | 1.2 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.4 | 3.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.4 | 3.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.4 | 4.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 1.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.4 | 1.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.4 | 0.8 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.4 | 1.9 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.4 | 1.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 1.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.4 | 1.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.4 | 4.4 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.4 | 1.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.4 | 1.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.4 | 0.4 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.4 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.4 | 0.4 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.4 | 0.7 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.4 | 2.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.4 | 3.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.4 | 0.7 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.4 | 1.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.4 | 4.6 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.4 | 0.7 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.4 | 1.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.3 | 2.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.3 | 3.5 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.3 | 17.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.3 | 0.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 1.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 0.7 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.3 | 1.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 0.7 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.3 | 1.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 0.7 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.3 | 1.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.3 | 0.3 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.3 | 2.0 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.3 | 1.0 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 0.7 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.3 | 16.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 0.7 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.3 | 1.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 1.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 1.0 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.3 | 1.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.3 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 2.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.3 | 1.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 2.7 | GO:0021766 | hippocampus development(GO:0021766) |
0.3 | 2.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 0.7 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 3.6 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 0.3 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 0.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 2.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 0.6 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.3 | 5.5 | GO:0003407 | neural retina development(GO:0003407) |
0.3 | 1.9 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.3 | 3.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.3 | 1.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.6 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 | 3.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 5.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 0.6 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 0.3 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.3 | 0.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.3 | 0.9 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.3 | 0.9 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 2.4 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 0.3 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.3 | 0.9 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 1.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 1.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.3 | 0.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.3 | 0.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 5.7 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.3 | 0.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.3 | 1.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 1.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 0.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.3 | 0.9 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.3 | 0.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.3 | 0.3 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.3 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 0.6 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 0.6 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 0.6 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 0.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 0.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 0.6 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.3 | 3.2 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 0.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 0.6 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.3 | 1.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 0.6 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.3 | 4.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.3 | 1.4 | GO:0032095 | regulation of response to food(GO:0032095) |
0.3 | 1.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.3 | 1.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.3 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.3 | 0.6 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.3 | 0.3 | GO:2000721 | pilomotor reflex(GO:0097195) positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.3 | 0.8 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 2.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.3 | 2.5 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.3 | 2.5 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.3 | 0.8 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 1.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 1.6 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.3 | 1.1 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.3 | 0.3 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 0.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.3 | 1.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.3 | 1.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 1.1 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.3 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 0.8 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.3 | 1.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 0.5 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.5 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 3.4 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.3 | 1.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 1.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.3 | 1.5 | GO:0032094 | response to food(GO:0032094) |
0.3 | 0.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 0.3 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.3 | 1.3 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.3 | 0.5 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.3 | 0.5 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.3 | 3.3 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.3 | 0.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.5 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 0.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 1.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 1.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.5 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 1.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.7 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.2 | 0.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.2 | 6.6 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.2 | 0.7 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 1.4 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 1.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 0.5 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 0.7 | GO:0038001 | paracrine signaling(GO:0038001) |
0.2 | 0.2 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
0.2 | 0.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.2 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.2 | 0.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 1.6 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.2 | 1.8 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.2 | 0.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 1.6 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 0.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.9 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.2 | 0.4 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.2 | 0.6 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 2.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 0.2 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 0.8 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 0.8 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 1.5 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.2 | 0.2 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.2 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.6 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 1.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 1.0 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.2 | 5.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.8 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.2 | 5.9 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 0.6 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 0.2 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) intestine smooth muscle contraction(GO:0014827) |
0.2 | 0.4 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.2 | 1.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.8 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.2 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.2 | 0.4 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 5.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 1.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.6 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 0.2 | GO:0021983 | pituitary gland development(GO:0021983) |
0.2 | 0.2 | GO:0061525 | hindgut development(GO:0061525) |
0.2 | 0.4 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.2 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.2 | 9.9 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.2 | 1.4 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.2 | 0.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.2 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.2 | 0.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 0.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 1.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 0.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.2 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.2 | 0.2 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.2 | 0.5 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 0.9 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.2 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.2 | 1.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 0.9 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 1.8 | GO:0048747 | muscle fiber development(GO:0048747) |
0.2 | 0.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 3.9 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 0.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.2 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.7 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.5 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 1.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.2 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 0.5 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 1.8 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.2 | 0.2 | GO:0099612 | protein localization to axon(GO:0099612) |
0.2 | 1.4 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.2 | 0.3 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.2 | 0.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 2.2 | GO:0008542 | visual learning(GO:0008542) |
0.2 | 1.2 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.2 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.2 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.2 | 0.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 1.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 1.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.4 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 1.6 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.6 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 1.8 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.4 | GO:0071772 | response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.1 | 0.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.7 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.3 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.4 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.1 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.1 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.1 | 0.7 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.1 | GO:0070431 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.3 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.1 | 0.9 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 0.4 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.1 | 0.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 1.0 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.2 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.4 | GO:0032400 | melanosome localization(GO:0032400) |
0.1 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.2 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.9 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.2 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.6 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.6 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 1.4 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.1 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.1 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.1 | GO:0021756 | striatum development(GO:0021756) |
0.1 | 0.4 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 1.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.5 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 1.2 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
0.1 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.5 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.1 | GO:0002371 | dendritic cell cytokine production(GO:0002371) regulation of dendritic cell cytokine production(GO:0002730) |
0.1 | 0.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.3 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.3 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.3 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.6 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 1.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 1.2 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.1 | GO:0050803 | regulation of synapse structure or activity(GO:0050803) |
0.1 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.5 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 1.0 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 0.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.1 | 0.7 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.2 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.1 | 0.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 1.4 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.1 | 0.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.2 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.2 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.3 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.1 | GO:0036258 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
0.1 | 0.2 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 0.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.3 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 1.4 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.3 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.1 | 0.4 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.2 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.1 | 0.1 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 0.1 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.5 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.0 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 2.2 | GO:0050954 | sensory perception of mechanical stimulus(GO:0050954) |
0.0 | 0.2 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 0.0 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.0 | 0.3 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.1 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.0 | 0.0 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.0 | 0.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.0 | 0.2 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.2 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.8 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.1 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.0 | 0.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.0 | 0.8 | GO:0050808 | synapse organization(GO:0050808) |
0.0 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.2 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.1 | GO:0055093 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.0 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.0 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.5 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.1 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.0 | 0.0 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.0 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.0 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.9 | GO:0007409 | axonogenesis(GO:0007409) |
0.0 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.0 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.0 | GO:0044851 | hair cycle phase(GO:0044851) |
0.0 | 0.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 0.0 | GO:0015872 | dopamine transport(GO:0015872) |
0.0 | 0.0 | GO:0061308 | cardiac neural crest cell differentiation involved in heart development(GO:0061307) cardiac neural crest cell development involved in heart development(GO:0061308) |
0.0 | 0.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 19.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.6 | 23.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.4 | 9.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
2.2 | 8.7 | GO:0071953 | elastic fiber(GO:0071953) |
1.9 | 1.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.8 | 7.4 | GO:0044308 | axonal spine(GO:0044308) |
1.8 | 10.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.6 | 1.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.6 | 4.7 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.5 | 12.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.5 | 16.5 | GO:0043194 | axon initial segment(GO:0043194) |
1.5 | 4.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.4 | 11.3 | GO:0043083 | synaptic cleft(GO:0043083) |
1.4 | 60.8 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.4 | 4.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.3 | 12.0 | GO:0016342 | catenin complex(GO:0016342) |
1.3 | 3.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.2 | 3.7 | GO:0044393 | microspike(GO:0044393) |
1.2 | 3.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.2 | 7.1 | GO:0032584 | growth cone membrane(GO:0032584) |
1.2 | 11.6 | GO:0001527 | microfibril(GO:0001527) |
1.2 | 10.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.2 | 56.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.1 | 6.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.1 | 24.2 | GO:0044295 | axonal growth cone(GO:0044295) |
1.1 | 3.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.0 | 2.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.0 | 4.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.0 | 6.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.0 | 16.1 | GO:0005614 | interstitial matrix(GO:0005614) |
1.0 | 58.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.0 | 1.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.9 | 0.9 | GO:0097427 | microtubule bundle(GO:0097427) |
0.9 | 0.9 | GO:0034705 | potassium channel complex(GO:0034705) |
0.9 | 12.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.9 | 3.7 | GO:1990696 | USH2 complex(GO:1990696) |
0.9 | 1.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.9 | 1.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.9 | 12.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.9 | 22.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.9 | 5.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.9 | 0.9 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.9 | 3.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.9 | 10.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.8 | 9.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.8 | 1.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.8 | 6.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.8 | 5.7 | GO:0005883 | neurofilament(GO:0005883) |
0.8 | 3.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.8 | 10.9 | GO:0043196 | varicosity(GO:0043196) |
0.8 | 3.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.8 | 0.8 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.8 | 3.1 | GO:0097433 | dense body(GO:0097433) |
0.8 | 26.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.8 | 9.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.8 | 3.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 5.9 | GO:0005861 | troponin complex(GO:0005861) |
0.7 | 0.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.7 | 2.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.7 | 17.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.7 | 11.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.7 | 4.3 | GO:0030673 | axolemma(GO:0030673) |
0.7 | 2.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.7 | 0.7 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.6 | 1.9 | GO:0043511 | inhibin complex(GO:0043511) |
0.6 | 1.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 1.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.6 | 1.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 7.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.6 | 2.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.6 | 1.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.6 | 82.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.6 | 5.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.6 | 3.5 | GO:0043203 | axon hillock(GO:0043203) |
0.6 | 7.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.6 | 4.7 | GO:0016460 | myosin II complex(GO:0016460) |
0.6 | 1.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.6 | 1.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.6 | 1.7 | GO:1990393 | 3M complex(GO:1990393) |
0.6 | 2.8 | GO:0071437 | invadopodium(GO:0071437) |
0.6 | 1.1 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.5 | 2.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 16.7 | GO:0030315 | T-tubule(GO:0030315) |
0.5 | 3.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 1.0 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.5 | 2.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.5 | 4.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 1.0 | GO:0005914 | spot adherens junction(GO:0005914) |
0.5 | 5.8 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.5 | 12.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.5 | 5.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.5 | 33.5 | GO:0030426 | growth cone(GO:0030426) |
0.5 | 0.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.4 | 12.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.4 | 4.9 | GO:0005605 | basal lamina(GO:0005605) |
0.4 | 34.0 | GO:0060076 | excitatory synapse(GO:0060076) |
0.4 | 2.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.4 | 0.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 2.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 2.0 | GO:0071547 | piP-body(GO:0071547) |
0.4 | 1.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 0.8 | GO:1990357 | terminal web(GO:1990357) |
0.4 | 1.2 | GO:0043205 | fibril(GO:0043205) |
0.4 | 1.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 92.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.4 | 8.9 | GO:0032420 | stereocilium(GO:0032420) |
0.4 | 1.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.4 | 1.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.4 | 3.5 | GO:0097060 | synaptic membrane(GO:0097060) |
0.3 | 4.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 2.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 3.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 0.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 4.3 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 1.0 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 2.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 2.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 3.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 0.9 | GO:0000802 | transverse filament(GO:0000802) |
0.3 | 0.9 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.3 | 0.3 | GO:0044299 | C-fiber(GO:0044299) |
0.3 | 2.7 | GO:0031430 | M band(GO:0031430) |
0.3 | 35.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 0.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 0.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 15.3 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 0.8 | GO:0030427 | site of polarized growth(GO:0030427) |
0.3 | 6.9 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 1.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 7.6 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 0.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 1.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 2.8 | GO:0043679 | axon terminus(GO:0043679) |
0.2 | 0.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 2.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 2.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 3.4 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 1.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 1.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 5.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 1.5 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 8.2 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 1.7 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 0.4 | GO:0044447 | axoneme part(GO:0044447) |
0.2 | 12.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 0.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 7.6 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 1.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.2 | 1.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 1.0 | GO:0043034 | costamere(GO:0043034) |
0.2 | 0.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 2.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.7 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 6.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 6.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 5.3 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 0.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 1.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 1.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 2.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.6 | GO:0005818 | aster(GO:0005818) |
0.2 | 26.1 | GO:0045202 | synapse(GO:0045202) |
0.1 | 1.0 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 2.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 5.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.4 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.4 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 1.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.4 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.9 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 3.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 2.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 2.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 2.7 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.3 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 1.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.4 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 1.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 1.0 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.0 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 3.4 | GO:0043005 | neuron projection(GO:0043005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 15.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
4.3 | 8.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
3.6 | 10.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.6 | 10.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.7 | 5.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.6 | 2.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
2.4 | 21.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.3 | 11.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.3 | 9.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.2 | 8.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
2.2 | 11.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.2 | 8.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.2 | 4.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.1 | 4.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.1 | 10.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.0 | 14.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.0 | 6.1 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
2.0 | 10.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.0 | 9.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.9 | 7.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.8 | 7.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.8 | 5.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.8 | 7.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.8 | 8.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.7 | 5.0 | GO:0035939 | microsatellite binding(GO:0035939) |
1.7 | 5.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.7 | 6.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.7 | 8.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.7 | 6.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.6 | 4.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.6 | 3.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.6 | 4.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.6 | 7.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.5 | 3.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.5 | 3.0 | GO:0030172 | troponin C binding(GO:0030172) |
1.4 | 11.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.4 | 1.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.4 | 5.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.4 | 8.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.3 | 11.8 | GO:0038191 | neuropilin binding(GO:0038191) |
1.3 | 6.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.3 | 11.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.3 | 1.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.3 | 3.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.3 | 3.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.3 | 2.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.3 | 14.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.3 | 6.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.3 | 17.5 | GO:0008066 | ionotropic glutamate receptor activity(GO:0004970) glutamate receptor activity(GO:0008066) |
1.3 | 8.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.2 | 3.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.2 | 3.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.2 | 4.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.1 | 20.2 | GO:0005112 | Notch binding(GO:0005112) |
1.1 | 5.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.1 | 4.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.1 | 4.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.1 | 7.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.1 | 3.3 | GO:0034956 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
1.1 | 3.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.1 | 3.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.1 | 3.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.1 | 4.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.1 | 4.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.1 | 3.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.1 | 1.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.0 | 2.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.0 | 5.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.0 | 14.4 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.0 | 5.1 | GO:0048495 | Roundabout binding(GO:0048495) |
1.0 | 3.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.0 | 3.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.0 | 2.9 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.0 | 6.8 | GO:0003680 | AT DNA binding(GO:0003680) |
1.0 | 3.9 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.0 | 3.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.0 | 6.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.0 | 6.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.0 | 4.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.9 | 5.7 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.9 | 20.8 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.9 | 1.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.9 | 2.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.9 | 12.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.9 | 2.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.9 | 1.8 | GO:0031013 | troponin I binding(GO:0031013) |
0.9 | 2.7 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.9 | 10.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.9 | 7.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.9 | 23.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.9 | 26.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.9 | 2.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.9 | 23.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.9 | 7.8 | GO:0031432 | titin binding(GO:0031432) |
0.9 | 4.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.9 | 4.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.8 | 11.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.8 | 4.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.8 | 14.8 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.8 | 4.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.8 | 2.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.8 | 8.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.8 | 9.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.8 | 11.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.8 | 10.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.8 | 16.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.8 | 4.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.8 | 9.8 | GO:0031402 | sodium ion binding(GO:0031402) |
0.8 | 3.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.7 | 4.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.7 | 10.9 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.7 | 1.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.7 | 0.7 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.7 | 4.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.7 | 2.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.7 | 2.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.7 | 3.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.7 | 1.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.7 | 8.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.7 | 4.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.7 | 2.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.7 | 16.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.7 | 2.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.7 | 2.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.7 | 3.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 2.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.7 | 2.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.7 | 6.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.7 | 3.4 | GO:0036122 | BMP binding(GO:0036122) |
0.7 | 12.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.7 | 1.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.7 | 3.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.7 | 24.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.7 | 2.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.7 | 2.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.7 | 4.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.7 | 4.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.7 | 2.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.6 | 3.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.6 | 1.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.6 | 1.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.6 | 8.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.6 | 5.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.6 | 1.9 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.6 | 14.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.6 | 6.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.6 | 3.0 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.6 | 2.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 11.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.6 | 1.8 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.6 | 2.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 14.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.6 | 16.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.6 | 2.3 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.6 | 1.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.6 | 1.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.6 | 2.3 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.6 | 2.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.6 | 5.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.6 | 3.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.6 | 3.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.6 | 1.7 | GO:0071253 | connexin binding(GO:0071253) |
0.6 | 1.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.5 | 1.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.5 | 1.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.5 | 0.5 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.5 | 2.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.5 | 1.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 2.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.5 | 1.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.5 | 13.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 4.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.5 | 1.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.5 | 1.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 1.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.5 | 13.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.5 | 10.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.5 | 2.5 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.5 | 1.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 1.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.5 | 1.9 | GO:0097001 | ceramide binding(GO:0097001) |
0.5 | 8.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.5 | 1.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.5 | 0.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 2.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.5 | 1.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 13.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 4.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 2.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 4.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.4 | 9.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 3.9 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.4 | 3.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.4 | 6.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 8.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 2.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 1.7 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.4 | 2.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 2.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 1.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 4.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.4 | 2.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 1.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 0.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.4 | 3.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.4 | 1.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 1.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.4 | 0.8 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 1.2 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.4 | 4.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.4 | 0.8 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.4 | 0.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 1.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.4 | 9.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.4 | 4.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.4 | 0.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 1.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 0.8 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.4 | 13.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.4 | 4.1 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 2.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 0.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.4 | 4.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 1.9 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.4 | 5.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.4 | 1.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 1.8 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 3.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 2.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 2.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 15.2 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.4 | 6.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.4 | 0.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 2.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 1.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 0.7 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 0.7 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 1.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 4.2 | GO:0005272 | sodium channel activity(GO:0005272) |
0.3 | 2.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 3.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 0.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 1.4 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 1.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.3 | 1.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 1.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 1.3 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.3 | 2.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.3 | 2.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 1.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 1.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 1.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 1.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 1.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.3 | 0.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 1.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 2.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 0.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 0.9 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 1.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 1.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 4.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 0.9 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 0.9 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 0.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 1.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 1.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 3.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 0.8 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.3 | 7.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 0.3 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.3 | 2.6 | GO:0048038 | quinone binding(GO:0048038) |
0.3 | 1.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 1.0 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 7.7 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
0.3 | 3.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 3.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 2.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 1.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.3 | 0.8 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 16.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 0.7 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 98.2 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 1.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 0.7 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 2.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 1.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 17.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.9 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 3.3 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.2 | 1.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 1.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 1.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.2 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 1.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 2.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 4.8 | GO:0005262 | calcium channel activity(GO:0005262) |
0.2 | 1.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 21.9 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 1.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 17.4 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 0.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 3.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 1.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.8 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 8.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 0.5 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 4.9 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.4 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 4.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 3.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 1.4 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 1.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 2.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.3 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 3.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 2.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 2.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.4 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.6 | GO:0034580 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.9 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 1.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 1.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.1 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 3.9 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.5 | GO:0034796 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 1.3 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 1.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 1.7 | GO:0052638 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) O antigen polymerase activity(GO:0008755) lipopolysaccharide-1,6-galactosyltransferase activity(GO:0008921) cellulose synthase activity(GO:0016759) 9-phenanthrol UDP-glucuronosyltransferase activity(GO:0018715) 1-phenanthrol glycosyltransferase activity(GO:0018716) 9-phenanthrol glycosyltransferase activity(GO:0018717) 1,2-dihydroxy-phenanthrene glycosyltransferase activity(GO:0018718) phenanthrol glycosyltransferase activity(GO:0019112) alpha-1,2-galactosyltransferase activity(GO:0031278) dolichyl pyrophosphate Man7GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0033556) endogalactosaminidase activity(GO:0033931) lipopolysaccharide-1,5-galactosyltransferase activity(GO:0035496) dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042283) inositol phosphoceramide synthase activity(GO:0045140) alpha-(1->3)-fucosyltransferase activity(GO:0046920) indole-3-butyrate beta-glucosyltransferase activity(GO:0052638) salicylic acid glucosyltransferase (ester-forming) activity(GO:0052639) salicylic acid glucosyltransferase (glucoside-forming) activity(GO:0052640) benzoic acid glucosyltransferase activity(GO:0052641) chondroitin hydrolase activity(GO:0052757) dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity(GO:0052824) cytokinin 9-beta-glucosyltransferase activity(GO:0080062) |
0.0 | 0.1 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.4 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0005148 | 3-keto sterol reductase activity(GO:0000253) prolactin receptor binding(GO:0005148) |
0.0 | 0.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.0 | 0.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.5 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 3.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 15.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.0 | 5.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.9 | 15.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.8 | 0.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.8 | 21.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.8 | 37.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.7 | 32.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.7 | 16.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.7 | 5.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.7 | 9.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.7 | 22.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.7 | 1.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.7 | 16.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.6 | 1.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.6 | 21.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.6 | 10.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 10.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.6 | 8.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.6 | 16.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 11.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.5 | 79.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 4.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 20.8 | PID BMP PATHWAY | BMP receptor signaling |
0.5 | 6.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 6.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.5 | 2.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.5 | 30.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.5 | 6.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 2.8 | ST ADRENERGIC | Adrenergic Pathway |
0.5 | 6.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 3.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 5.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 2.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.4 | 8.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 4.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 6.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.4 | 1.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.4 | 8.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 1.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.4 | 4.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 8.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 1.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 5.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 6.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 42.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 80.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 6.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 3.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 0.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 2.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 4.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 5.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 2.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 6.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 1.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 1.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 25.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.5 | 20.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.5 | 1.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.5 | 31.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.5 | 1.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.5 | 2.9 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
1.5 | 33.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.4 | 48.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.4 | 1.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.2 | 12.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.2 | 1.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.1 | 12.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.1 | 20.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.1 | 2.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.1 | 12.7 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.0 | 43.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.0 | 39.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.0 | 3.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.0 | 10.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.9 | 0.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.8 | 10.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.8 | 3.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.8 | 8.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.8 | 17.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.8 | 6.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.7 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.7 | 1.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.7 | 2.8 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.7 | 7.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.7 | 6.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.6 | 14.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.6 | 0.6 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.6 | 2.5 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.6 | 5.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.6 | 24.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.6 | 8.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.6 | 7.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 7.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.6 | 2.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.6 | 7.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.6 | 2.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.6 | 4.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.6 | 36.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.5 | 9.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 9.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.5 | 18.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 4.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 5.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 4.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 11.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 0.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 0.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.4 | 2.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.4 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 1.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.4 | 0.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.4 | 3.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 4.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 2.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.4 | 1.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 2.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 5.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 2.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 1.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 5.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 4.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 2.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 4.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 5.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.3 | 3.7 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.3 | 5.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 4.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 42.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.3 | 5.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 1.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 2.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 4.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 2.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 2.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 0.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 2.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 0.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 1.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 2.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 0.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 0.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 1.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.3 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.1 | 1.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 5.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 4.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 4.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.3 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 3.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.5 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 2.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |